Virus detectives seek source of SARS in China's wild animals.
作者信息
Cyranoski David, Abbott Alison
出版信息
Nature. 2003 May 29;423(6939):467. doi: 10.1038/423467a.
Abstract
摘要
相似文献
1
Virus detectives seek source of SARS in China's wild animals.
Nature. 2003 May 29;423(6939):467. doi: 10.1038/423467a.
2
Infectious diseases. Civets back on China's menu.
Science. 2003 Aug 22;301(5636):1031. doi: 10.1126/science.301.5636.1031a.
3
Infectious diseases. Clues to the animal origins of SARS.
Science. 2003 May 30;300(5624):1351. doi: 10.1126/science.300.5624.1351a.
4
Antibodies to SARS-like virus hint at repeated infections.
Nature. 2004 Jan 15;427(6971):185. doi: 10.1038/427185a.
5
SARS in China. Tracking the roots of a killer.
Science. 2003 Jul 18;301(5631):297-9. doi: 10.1126/science.301.5631.297.
6
Bat cave solves mystery of deadly SARS virus - and suggests new outbreak could occur.
Nature. 2017 Dec 7;552(7683):15-16. doi: 10.1038/d41586-017-07766-9.
7
Virology. Researchers tie deadly SARS virus to bats.
Science. 2005 Sep 30;309(5744):2154-5. doi: 10.1126/science.309.5744.2154.
8
Bats and human emerging diseases.
Epidemiol Infect. 2006 Oct;134(5):905-7. doi: 10.1017/S0950268806006674. Epub 2006 Jun 2.
9
SARS in China. China's missed chance.
Science. 2003 Jul 18;301(5631):294-6. doi: 10.1126/science.301.5631.294.
10
Virology: SARS virus infection of cats and ferrets.
Nature. 2003 Oct 30;425(6961):915. doi: 10.1038/425915a.
引用本文的文献
1
Potential Drugs in COVID-19 Management.
Curr Med Chem. 2024;31(22):3245-3264. doi: 10.2174/0929867331666230717154101.
2
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research.
Hum Vaccin Immunother. 2020 Dec 1;16(12):3043-3054. doi: 10.1080/21645515.2020.1807802. Epub 2020 Sep 11.
3
COVID-19: The Conjunction of Events Leading to the Coronavirus Pandemic and Lessons to Learn for Future Threats.
Front Med (Lausanne). 2020 May 12;7:223. doi: 10.3389/fmed.2020.00223. eCollection 2020.
4
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
Microbes Infect. 2020 Jul-Aug;22(6-7):245-253. doi: 10.1016/j.micinf.2020.05.004. Epub 2020 May 11.
5
The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.
Indian J Med Res. 2020;151(2 & 3):147-159. doi: 10.4103/ijmr.IJMR_519_20.
6
Bioinformatical study on the proteomics and evolution of SARS-CoV.
Chin Sci Bull. 2003;48(13):1277-1287. doi: 10.1007/BF03184163.
7
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06.
8
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
Vaccine. 2006 Jun 29;24(26):5498-508. doi: 10.1016/j.vaccine.2006.04.054. Epub 2006 May 11.
9
A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity.
Biochem Biophys Res Commun. 2006 May 26;344(1):106-13. doi: 10.1016/j.bbrc.2006.03.139. Epub 2006 Mar 30.
10
SARS-associated coronavirus replication in cell lines.
Emerg Infect Dis. 2006 Jan;12(1):128-33. doi: 10.3201/eid1201.050496.
Zotero 插件